As of 2026-03-15, the Intrinsic Value of Biophytis SA (ALBPS.PA) is -0.75 EUR. This ALBPS.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.03 EUR, the upside of Biophytis SA is -2,420.61%.
Based on its market price of 0.03 EUR and our intrinsic valuation, Biophytis SA (ALBPS.PA) is overvalued by 2,420.61%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.75 - -0.75 | -0.75 | -2,420.61% |
| P/E | (0.35) - (0.84) | (0.61) | -1976.3% |
| DDM - Stable | (0.36) - (1.48) | (0.92) | -2949.1% |
| DDM - Multi | (0.36) - (1.30) | (0.58) | -1889.5% |
| Market Cap (mil) | 2.47 |
| Beta | -0.32 |
| Outstanding shares (mil) | 76.51 |
| Enterprise Value (mil) | 7.60 |
| Market risk premium | 5.82% |
| Cost of Equity | 17.29% |
| Cost of Debt | 5.00% |
| WACC | 6.96% |